Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr101 Inhibitors

Olfr101 inhibitors are a diverse group of chemicals that indirectly influence the activity of the Olfactory Receptor 101. These inhibitors primarily target signaling pathways and cellular processes that are upstream or downstream of the receptor's function. Olfr101, like other olfactory receptors, is part of the G protein-coupled receptor (GPCR) family, which is why most of these inhibitors focus on modulating the GPCR signaling pathway. This pathway is intricate, involving a series of enzymatic reactions and protein interactions that ultimately lead to olfactory signal transduction. The chemicals listed target various components of this signaling cascade, such as adenylate cyclase, protein kinases, phospholipases, and MAP kinases. The inhibition methods employed by these chemicals are diverse. For example, Forskolin increases cAMP levels by activating adenylate cyclase, indirectly influencing the receptor's signaling mechanism.

On the other hand, compounds like U73122 and LY294002 act by inhibiting key enzymes like phospholipase C and PI3K, respectively, thus modulating the downstream effects of receptor activation. Staurosporine and Genistein exhibit broader activity, targeting multiple kinases and potentially affecting several pathways simultaneously. This broad approach is necessary due to the complex nature of GPCR signaling and the lack of direct inhibitors specific to Olfr101. The study of these inhibitors is crucial in understanding the molecular dynamics of olfactory receptors. By analyzing how these chemicals influence Olfr101, researchers can gain insights into the receptor's role in olfactory signaling and potentially uncover new aspects of olfactory perception. Additionally, this knowledge aids in the development of more targeted and efficient inhibitors, which could have implications in various research contexts. It's important to note that while these inhibitors provide valuable tools for studying Olfr101, their effects on other proteins and pathways should be considered, as they are not exclusive to this specific receptor.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A inhibits protein transport and interferes with the G protein-coupled receptor (GPCR) signaling pathway, which may indirectly affect Olfr101.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin activates adenylate cyclase, modulating cAMP levels, which are crucial in olfactory signaling, potentially influencing Olfr101.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

KT5720 is a potent inhibitor of protein kinase A (PKA), a key player in the GPCR pathway, thus indirectly affecting Olfr101 activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor, affecting downstream signaling pathways involved in GPCR function, which may influence Olfr101.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine broadly inhibits protein kinases, affecting multiple pathways including those related to GPCR signaling, possibly impacting Olfr101.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 specifically inhibits MEK, which is part of the MAPK/ERK pathway linked to GPCR signaling, potentially affecting Olfr101.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor, which may indirectly affect the signaling pathways associated with Olfr101.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor, influencing pathways that can indirectly impact Olfr101 activity.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a potent inhibitor of PI3K, which can indirectly affect GPCR-related pathways, potentially influencing Olfr101.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

GF109203X is a protein kinase C inhibitor, which can modify signaling pathways related to Olfr101 function.